Gomperts ED - Search Results

1

Anaphylaxis after treatment with recombinant factor VIII.

Shopnick RI, Kazemi M, Brettler DB, Buckwalter C, Yang L, Bray G, Gomperts ED. Shopnick RI, et al. Among authors: gomperts ed. Transfusion. 1996 Apr;36(4):358-61. doi: 10.1046/j.1537-2995.1996.36496226153.x. Transfusion. 1996. PMID: 8623140

2

Antibodies to heterologous proteins in hemophilia A patients receiving recombinant factor VIII (Recombinate).

Ingerslev J, Christiansen K, Ravn HB, Bray GL, Gomperts ED; Recombinate Study Group. Ingerslev J, et al. Among authors: gomperts ed. Thromb Haemost. 2002 Apr;87(4):626-34. Thromb Haemost. 2002. PMID: 12008945 Clinical Trial.

3

A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with hemophilia A. The Recombinate Previously Treated Patient Study Group.

White GC 2nd, Courter S, Bray GL, Lee M, Gomperts ED. White GC 2nd, et al. Among authors: gomperts ed. Thromb Haemost. 1997 Apr;77(4):660-7. Thromb Haemost. 1997. PMID: 9134639 Clinical Trial.

4

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, Shapiro A, Scheibel E, White G 3rd, Lee M. Bray GL, et al. Among authors: gomperts ed. Blood. 1994 May 1;83(9):2428-35. Blood. 1994. PMID: 8167332 Free article. Clinical Trial.

5

Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay.

Lee CA, Owens D, Bray G, Giangrande P, Collins P, Hay C, Gomperts E, Schroth P, Barrowcliffe T. Lee CA, et al. Thromb Haemost. 1999 Dec;82(6):1644-7. Thromb Haemost. 1999. PMID: 10613649 Clinical Trial.

6

Comparison of high responder inhibitor frequency in recent studies of previously untreated patients with hemophilia A.

Ehrlich HJ, Bray GL, Gomperts ED. Ehrlich HJ, et al. Among authors: gomperts ed. Thromb Haemost. 1998 Jan;79(1):242-3. Thromb Haemost. 1998. PMID: 9459360 Clinical Trial. No abstract available.

7

A multicenter study of recombinant factor VIII (Recombinate(TM) ) in previously treated patients with hemophilia A.

White GC, Courter S, Bray GL, Lee M, Gomperts ED. White GC, et al. Among authors: gomperts ed. Haemophilia. 1997 Jul;3(3):232. doi: 10.1046/j.1365-2516.1997.t01-4-00125.x. Haemophilia. 1997. PMID: 27214819 No abstract available.

8

Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A.

Kruse-Jarres R, St-Louis J, Greist A, Shapiro A, Smith H, Chowdary P, Drebes A, Gomperts E, Bourgeois C, Mo M, Novack A, Farin H, Ewenstein B. Kruse-Jarres R, et al. Haemophilia. 2015 Mar;21(2):162-170. doi: 10.1111/hae.12627. Epub 2015 Jan 27. Haemophilia. 2015. PMID: 25623166 Clinical Trial.

9

The manufacturing process of recombinant factor VIII, recombinate.

Gomperts E, Lundblad R, Adamson R. Gomperts E, et al. Transfus Med Rev. 1992 Oct;6(4):247-51. doi: 10.1016/s0887-7963(92)70175-8. Transfus Med Rev. 1992. PMID: 1421823 Review.

10

Pharmacokinetic in vivo comparison using 1-stage and chromogenic substrate assays with two formulations of Hemofil-M.

Lee C, Barrowcliffe T, Bray G, Gomperts E, Hubbard A, Kemball-Cook G, Lilley P, Owens D, Von Tilberg L, Pasi J. Lee C, et al. Thromb Haemost. 1996 Dec;76(6):950-6. Thromb Haemost. 1996. PMID: 8972016 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters